AAAAAA

   
Results: 1-6 |
Results: 6

Authors: BRUSERUD O ULVESTAD E BERENTSEN S BERGHEIM J NESTHUS I
Citation: O. Bruserud et al., T-LYMPHOCYTE FUNCTIONS IN ACUTE-LEUKEMIA PATIENTS WITH SEVERE CHEMOTHERAPY-INDUCED CYTOPENIA - CHARACTERIZATION OF CLONOGENIC T-CELL PROLIFERATION, Scandinavian journal of immunology, 47(1), 1998, pp. 54-62

Authors: BERENTSEN S BO K SHAMMAS FV MYKING AO ULVESTAD E
Citation: S. Berentsen et al., CHRONIC COLD AGGLUTININ DISEASE OF THE IDIOPATHIC TYPE IS A PREMALIGNANT OR LOW-GRADE MALIGNANT LYMPHOPROLIFERATIVE DISEASE, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 105(5), 1997, pp. 354-362

Authors: BRUSERUD O ULVESTAD E HALSTENSEN A BERENTSEN S BERGHEIM J NESTHUS I
Citation: O. Bruserud et al., INTERLEUKIN-4 RESPONSES IN ACUTE-LEUKEMIA PATIENTS WITH SEVERE CHEMOTHERAPY-INDUCED LEUKOPENIA, European journal of haematology, 59(5), 1997, pp. 269-276

Authors: BERENTSEN S STOLZ T MOLT K
Citation: S. Berentsen et al., ANALYSIS OF AQUEOUS-SOLUTIONS BY NEAR-INFRARED SPECTROMETRY (NIRS) .4. ONE-COMPONENT AND 2-COMPONENT SYSTEMS OF ORGANIC-COMPOUNDS IN WATER, Journal of molecular structure, 410, 1997, pp. 581-585

Authors: BRUSERUD O MENTZONI L FOSS B BERGHEIM J BERENTSEN S NESTHUS I
Citation: O. Bruserud et al., HUMAN T-LYMPHOCYTE ACTIVATION IN THE PRESENCE OF ACUTE MYELOGENOUS LEUKEMIA BLASTS - STUDIES OF ALLOSTIMULATED INTERFERON-GAMMA SECRETION, Cancer immunology and immunotherapy, 43(5), 1996, pp. 275-282

Authors: HJORTH M WESTIN J DAHL IMS GIMSING P HIPPE E HOLMBERG E LAMVIK J NIELSEN JL LOFVENBERG E PALVA IP RODJER S TALSTAD I TURESSON I WISLOFF F ZADOR G AMSLERNORDIN S POLGARY M ODEN A WALLGREN A WILHELMSEN L HELLQVIST L HASSELBLOM S CARNESKOG J LINDQVIST O HOFFMAN P OLSSON K THOLEN A STOLT CM RINDNER A SVENSSON R VAART J HANSEN S ENGQVIST L LANNEMYR O NILSSON PG LINNE I LILJA G TALLROTH G HALLGREN J ANDERSSON B BILLSTROM R PERSSON S SAMUELSSON T ODEBERG H ADRIANSSON M TOVE H STOBEUS N HABBERSTAD J END T DAHLEN M ERIKSSON M ANAGRIUS N ARONSON D NEZADAL L ERIKSSON K HEDENUS M RYDE J WESTIN L ANDERSSON LO BJURMAN A FORSBERG K FORS D WIKSTROM S THULE B BOLSOY U LENNERMO K STRAND T PALVA I ALMQVIST A ISOMAA B OKSANEN K EIKA C LY B BRANDT E WEYDE K FOSSUM C LOVASEN K SPARBY JA JACOBSEN EM RINDE M NYHUS S KAHRS J STEEN T GRAVDAHL H BORGE L GROTTUM KA FLOTTEROD O STROM BR KNUTSEN H DRIVENES A PAULSEN J RIIS S HAUGE PW NESTHUS I COLL P HOLE KH SAETER T SINDRE T BERENTSEN S NES H VAGSTAD G HEIKKELA R SHAMMAS V LODEMEL B SKOGEN OR SORUM Y KVAMBE V BULL O JAEGER S INGVALDSEN PG PEDERSEN K HANSEN LT ONKIEHONG M HAUGNES T STEFANSEN D GADEBERG O ABILDGAARD N JANS H MOURITSANDERSEN T NEUBAUER B CLAUSEN NT MAGNUSSON S EYJOLFSSON G BJORNSSON S
Citation: M. Hjorth et al., INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 124(2), 1996, pp. 212
Risultati: 1-6 |